Incyte Names Soni Basi as Executive Vice President and Chief Human Resources Officer

Incyte has appointed Soni Basi as Executive Vice President and Chief Human Resources Officer, effective August 25, 2025. Basi brings over 25 years of global HR experience and will be tasked with shaping the company's global human resources strategy, focusing on talent acquisition, organizational design, and professional development. She succeeds Paula Swain, who is retiring. Basi's extensive knowledge in all facets of human resources will be instrumental in Incyte's growth.

Incyte (Nasdaq:INCY) has announced the appointment of Soni Basi as Executive Vice President and Chief Human Resources Officer (CHRO), effective August 25, 2025. In her new role, Ms. Basi will serve as a key member of the Executive Leadership Team and be responsible for shaping the Company’s global human resources strategy, including talent acquisition, organizational design, and professional development [1].

Ms. Basi brings over 25 years of experience in global HR and business leadership. She is recognized for leading high-performing HR teams and managing organizational transformation. Prior to joining Incyte, Ms. Basi was CHRO at Edelman, overseeing a team of over 200 HR professionals. She also held leadership roles in global talent at AIG, Allergan Pharmaceuticals, The Estée Lauder Companies, and Schering-Plough. Ms. Basi earned her M.A. and Ph.D. in Social Psychology from Bowling Green State University [1].

“Soni has extensive knowledge and experience in all aspects of human resources,” said Bill Meury, President and Chief Executive Officer, Incyte. “She is a skilled professional and collaborative leader who will bring a strategic mindset and operational focus to the company. Soni will play a key role in attracting, developing, and retaining top talent at Incyte and preparing the organization for the next phase of growth” [1].

Ms. Basi succeeds Paula Swain, Incyte’s former Executive Vice President and Head of Human Resources, who is retiring. Incyte is a global biopharmaceutical company dedicated to finding solutions for patients with unmet medical needs. The company has a portfolio of first-in-class medicines and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe, and Asia [1].

Incyte’s forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including unanticipated developments in and risks related to further research and development, clinical trial results, regulatory approvals, market competition, and variations in foreign currency exchange rates [1].

References:
[1] https://www.morningstar.com/news/business-wire/20250825285714/incyte-announces-the-appointment-of-soni-basi-as-executive-vice-president-and-chief-human-resources-officer
[2] https://www.businesswire.com/news/home/20250825285714/en/Incyte-Announces-the-Appointment-of-Soni-Basi-as-Executive-Vice-President-and-Chief-Human-Resources-Officer